By Robert Muggah for IPI Global Observatory. The much-anticipated United Nations special session on the world drug problem—known as UNGASS—fell on its face this week. The final outcome document was hastily signed on the first day of the three-day event. It turns out to be long on rhetoric and short on substance. While offering lip service to population health and access to medicines, it is jarringly out of step with public sentiment around the world. Rather than drawing on new evidence of what works, it doubles down on the status quo.